Ariad Pharmaceuticals Inc fka ARIA

[vidpok45]

All these rather dismal projections for the share price fail to factor in the very significant pressure on all small and midcap biotechs in the current market. In a more favorable environment we would see a much higher value on the company with a stock price in mid teens by now. Would like to see biotechs back in favor about the time we start to hear about 113 in the summer.